Testing effectiveness (Phase 2)Study completedNCT04051606
What this trial is testing
Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
Who this might be right for
Recurrent Glioblastoma
Case Comprehensive Cancer Center 14
Showing 20 of 0 results